Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

被引：1
|
作者：
Warner, Nadia [1 ]
Locarnini, Stephen [1 ]
机构：
[1] Victorian Infect Dis Reference Labs, Melbourne, Vic, Australia
来源：
ANTIVIRAL THERAPY | 2009年 / 14卷 / 02期
关键词：
VIRUS-DNA; TRANSMEMBRANE TOPOLOGY; TRANSCRIPTIONAL TRANSACTIVATOR; LAMIVUDINE THERAPY; PRES/S-SEQUENCES; SURFACE-ANTIGEN; YMDD-MOTIF; INFECTION; REGION; GENOTYPE;
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：139 / 142
页数：4
相关论文
共 50 条
  • [21] Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok, Anna Suk-Fong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (02) : 221 - 227
  • [22] Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis
    Gao, Xuesong
    Yang, Hwai-, I
    Trinh, Huy
    Jeong, Donghak
    Li, Jiayi
    Zhang, Jian
    Le, An
    Hoang, Joseph
    Nguyen, Pauline
    Henry, Linda
    Nguyen, Mindie H.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (09) : 1207 - 1211
  • [23] Antiviral therapy using lamivudine and thymosin α1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection
    Cheng, SQ
    Wu, MC
    Chen, H
    Shen, F
    Yang, JH
    Cong, WM
    Yin, ZF
    Zhao, YX
    Wang, PJ
    HEPATO-GASTROENTEROLOGY, 2006, 53 (68) : 249 - 252
  • [24] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B INFECTION AFTER PERSISTENT VIRAL SUPPRESSION WITH ANTIVIRAL THERAPY
    Decharatanachart, Pakanat
    Tangkijvanich, Pisit
    Treeprasertsuk, Sombat
    Rerknimitr, Rungsun
    Chaiteerakij, Roongruedee
    GASTROENTEROLOGY, 2023, 164 (06) : S1363 - S1363
  • [25] Impact of Antiviral Therapy on Risk Prediction Models for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
    Chon, Hye Yeon
    Lim, Tae Seop
    Jeon, MiYoung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Kim, Seunq Up
    HEPATOLOGY, 2018, 68 : 1231A - 1232A
  • [26] THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY
    Alshuwaykh, Omar
    Goel, Aparna
    Daugherty, Tami
    Cheung, Amanda
    Kim, W. Ray
    Kwong, Allison J.
    Ahmed, Aijaz
    Ghaziani, T. Tahereh
    Torok, Natalie J.
    Nguyen, Mindie H.
    Dronamraju, Deepti
    Dhanasekaran, Renumathy
    Kumari, Radhika
    Kwo, Paul Y.
    HEPATOLOGY, 2020, 72 : 472A - 473A
  • [27] Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
    Lin, Chih-Lang
    Wu, Szu-Yuan
    Lai, Ming-Wei
    Hsu, Chao-Wei
    Chen, Wan-Ming
    Jao, An-Tzu
    Chien, Cheng-Hung
    Hu, Ching-Chih
    Chien, Rong-Nan
    Yeh, Chau-Ting
    CANCERS, 2023, 15 (13)
  • [28] Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy
    Alshuwaykh, Omar
    Daugherty, Tami
    Cheung, Amanda
    Goel, Aparna
    Dhanasekaran, Renumathy
    Ghaziani, T. Tara
    Ahmed, Aijaz
    Dronamraju, Deepti
    Kumari, Radhika
    Kwong, Allison
    Nguyen, Mindie
    Kim, W. Ray
    Kwo, Paul Yien
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (11) : 3052 - 3061
  • [29] Risk assessment of hepatocellular carcinoma in chronic hepatitis B patients with long-term antiviral therapy
    Chung, Kyu Sik
    Kim, Do Young
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Ku, Hye Jin
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    HEPATOLOGY, 2015, 62 : 385A - 385A
  • [30] RISK ASSESSMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS WITH LONG-TERM ANTIVIRAL THERAPY
    Chung, K. S.
    Lee, H. W.
    Kim, D. Y.
    Kim, B. K.
    Kim, S. U.
    Park, J. Y.
    Han, K. -H.
    Ahn, S. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S517 - S517
12345